Neuropsychological functioning in healthy people and people with a history of cannabis use

Authors

  • Walter Alexander de Paz Orozco Universidad de San Carlos de Guatemala

DOI:

https://doi.org/10.46780/cunzac.v7i2.136

Keywords:

cannabis, neuropsychological domains, neurocognitive alteration

Abstract

PROBLEM: cannabis is considered an illicit drug; chronic frequent consumption of cannabis alters the central nervous system both at a structural and functional level that affects the alteration of the different neurocognitive domains. OBJECTIVE: to identify neuropsychological functioning in healthy people and people with a history of cannabis use to determine if there are statistically differences of 0.05% in both groups. METHOD: the type of study is with a descriptive-comparative approach, the statistical test used was Student's t and p value. The convenience sample is made up of 20 people, 10 who consume cannabis and 10 who do not consume, between the ages of 18 and 59. RESULTS: discrepancies were found in the different subdomains such as auditory, divided, and sustained attention, which were measured with the BTA test, obtaining a p-value score of 0.01%. Processing speed, visual tracking, cognitive impairment and shared attention were measured by the SDMT test, reaching a p-value of 0.01%. And, finally, phonetic fluency S, planning, speed in accessing words, and ability to execute reached a p-value of 0.03%. CONCLUSION: the results indicate that there is a statistically significant difference at 0.05 in neuropsychological functioning in people who consume cannabis compared to people who do not consume cannabis.

Downloads

Download data is not yet available.

Author Biography

Walter Alexander de Paz Orozco, Universidad de San Carlos de Guatemala

Posee el grado de licenciatura en Psicología clínica, con especialización de Experto en Neuropsicología infantil, con Postgrado en Neuropsicología y Evaluación Cognitiva, con Especialidad en Psiquiatría y Psicología forense y rehabilitación neuropsicológica en personas con daño cerebral, se dedica a la atención clínica y comunitaria. Además, también realiza docencia universitaria en dos diferentes sedes como la Universidad Da Vinci de Guatemala y la Universidad Regional de Guatemala

References

Bogaty, S. E. R., Crouse, J. J., Hickie, I. B., & Hermens, D. F. (2019). The neuropsychological profiles of young psychosis patients with and without current cannabis use. Cognitive neuropsychiatry, 24(1), 40–53. https://doi.org/10.1080/13546805.2018.1562887. DOI: https://doi.org/10.1080/13546805.2018.1562887

De Vos, C., Leopold, K., Blanke, E. S., Siebert, S., Baumgardt, J., Burkhardt, E., & Bechdolf, A. (2020). The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis. Psychiatry research, 293, 113424. https://doi.org/10.1016/j.psychres.2020.113424. DOI: https://doi.org/10.1016/j.psychres.2020.113424

Dhein S. (2020). Different Effects of Cannabis Abuse on Adolescent and Adult Brain. Pharmacology, 105(11-12), 609–617. https://doi.org/10.1159/000509377 DOI: https://doi.org/10.1159/000509377

Estebsari, F., Dastoorpoor, M., Khalifehkandi, Z. R., Nouri, A., Mostafaei, D., Hosseini, M., Esmaeili, R., & Aghababaeian, H. (2020). The Concept of Successful Aging: A Review Article. Current aging science, 13(1), 4–10. https://doi.org/10.2174/1874609812666191023130117 DOI: https://doi.org/10.2174/1874609812666191023130117

Francisco, A. P., Lethbridge, G., Patterson, B., Goldman Bergmann, C., & Van Ameringen, M. (2023). Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review. Journal of psychiatric research, 157, 239–256. https://doi.org/10.1016/j.jpsychires.2022.11.029 DOI: https://doi.org/10.1016/j.jpsychires.2022.11.029

Friedman S. M. (2020). Lifestyle (Medicine) and Healthy Aging. Clinics in geriatric medicine, 36(4), 645–653. https://doi.org/10.1016/j.cger.2020.06.007 DOI: https://doi.org/10.1016/j.cger.2020.06.007

Griffin, A., Deeba, F., Dennison, T., & Moore, A. (2020). Perspectives on neuropsychology and clinical care in paediatric and adolescent medicine. Clinical child psychology and psychiatry, 25(3), 687–697. https://doi.org/10.1177/1359104520915249. DOI: https://doi.org/10.1177/1359104520915249

Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019). Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects. The Journal of neuroscience: the official journal of the Society for Neuroscience, 39(42), 8250–8258. https://doi.org/10.1523/JNEUROSCI.1165-19.2019 DOI: https://doi.org/10.1523/JNEUROSCI.1165-19.2019

Marquez, D. X., Aguiñaga, S., Vásquez, P. M., Conroy, D. E., Erickson, K. I., Hillman, C., Stillman, C. M., Ballard, R. M., Sheppard, B. B., Petruzzello, S. J., King, A. C., & Powell, K. E. (2020). A systematic review of physical activity and quality of life and well-being. Translational behavioral medicine, 10(5), 1098–1109. https://doi.org/10.1093/tbm/ibz198 DOI: https://doi.org/10.1093/tbm/ibz198

Meier, M. H., Caspi, A., R Knodt, A., Hall, W., Ambler, A., Harrington, H., Hogan, S., M Houts, R., Poulton, R., Ramrakha, S., Hariri, A. R., & Moffitt, T. E. (2022). Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife. The American journal of psychiatry, 179(5), 362–374. https://doi.org/10.1176/appi.ajp.2021.21060664 DOI: https://doi.org/10.1176/appi.ajp.2021.21060664

Ortega-Mora, I. E., Caballero-Sánchez, U., Román-López, T. V., Rosas-Escobar, C. B., Méndez-Díaz, M., Prospéro-García, O. E., & Ruiz-Contreras, A. E. (2021). The Alerting and Orienting Systems of Attention Are Modified by Cannabis Dependence. Journal of the International Neuropsychological Society: JINS, 27(6), 520–532. https://doi.org/10.1017/S1355617721000369 DOI: https://doi.org/10.1017/S1355617721000369

Poveda-Rios, S. (2017). Evaluación de la memoria en consumidores de cannabis. http://repositorio.pucesa.edu.ec/handle/123456789/2341

Ramaekers, J. G., Theunissen, E. L., van Ruitenbeek, P., & Mason, N. L. (2022). Cannabis Use and Neuroadaptation: A Call for Δ 9 -Tetrahydrocannabinol Challenge Studies. Frontiers in psychiatry, 13, 870750. https://doi.org/10.3389/fpsyt.2022.870750 DOI: https://doi.org/10.3389/fpsyt.2022.870750

Soler Artigas, M., Sánchez-Mora, C., Rovira, P., Richarte, V., Garcia-Martínez, I., Pagerols, M., Demontis, D., Stringer, S., ADHD Group of the Psychiatric Genomics

Consortium, International Cannabis Consortium, Vink, J. M., Børglum, A. D., Neale, B. M., Franke, B., Faraone, S. V., Casas, M., Ramos-Quiroga, J. A., & Ribasés, M. (2020). Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Molecular psychiatry, 25(10), 2493–2503. https://doi.org/10.1038/s41380-018-0339-3 DOI: https://doi.org/10.1038/s41380-018-0339-3

Urits, I., Charipova, K., Gress, K., Li, N., Berger, A. A., Cornett, E. M., Kassem, H., Ngo, A. L., Kaye, A. D., & Viswanath, O. (2021). Adverse Effects of Recreational and Medical Cannabis. Psychopharmacology bulletin, 51(1), 94–109. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063125/

Published

2024-07-28

How to Cite

de Paz Orozco, W. A. (2024). Neuropsychological functioning in healthy people and people with a history of cannabis use. Revista Académica CUNZAC, 7(2), 30–44. https://doi.org/10.46780/cunzac.v7i2.136